Literature DB >> 21308654

Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.

O A Uyar1, M Kara, D Erol, A Ardicoglu, H Yuce.   

Abstract

Increased oxidative stress can help promote carcinogenesis, including development of renal cell carcinoma. The enzyme protects low-density lipoproteins from oxidation and can be a factor in this process. PON1 Q192R and L55M paraoxonase gene polymorphisms were assessed in 60 renal cell carcinoma patients and 60 healthy controls. Genotypes were examined by PCR; the restriction enzyme AlwI was used to examine the Q192R polymorphism and Hsp92II for the L55M polymorphism. Significant differences in the PON1 Q192R polymorphism were found between patients and controls. The Q allele was more frequent in the patient group than in controls, while the R allele was more frequent in the control group. No significant differences were found in the L55M polymorphism. Additionally, there were no significant differences in L and M allele frequencies. We conclude that the R allele may protect against renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21308654     DOI: 10.4238/vol10-1gmr927

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  5 in total

1.  Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies.

Authors:  Dai-Hua Fang; Cong-Hai Fan; Qiang Ji; Bo-Xiang Qi; Juan Li; Lu Wang
Journal:  Mol Biol Rep       Date:  2012-02-10       Impact factor: 2.316

2.  Protectors or Traitors: The Roles of PON2 and PON3 in Atherosclerosis and Cancer.

Authors:  Ines Witte; Ulrich Foerstermann; Asokan Devarajan; Srinivasa T Reddy; Sven Horke
Journal:  J Lipids       Date:  2012-05-13

3.  Association between L55M polymorphism in Paraoxonase 1 and cancer risk: a meta-analysis based on 21 studies.

Authors:  Lei Chen; Wei Lu; Lu Fang; Hu Xiong; Xun Wu; Meng Zhang; Song Wu; Dexin Yu
Journal:  Onco Targets Ther       Date:  2016-03-04       Impact factor: 4.147

4.  Iron-Bound Lipocalin-2 Protects Renal Cell Carcinoma from Ferroptosis.

Authors:  Julia K Meier; Matthias Schnetz; Susanne Beck; Tobias Schmid; Monica Dominguez; Sanela Kalinovic; Andreas Daiber; Bernhard Brüne; Michaela Jung
Journal:  Metabolites       Date:  2021-05-19

5.  Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms and renal cancer risk.

Authors:  ZhiHong Liu; YingMing Xiao; LiangYou Tang; Liang Jiang; YuJie Wang; RuoChen Zhang; Qiang Wei; YiPing Lu
Journal:  Lipids Health Dis       Date:  2015-11-04       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.